| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | 2.16.840.1.113762.1.4.1110.50 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1110.50/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.50 |
| Version | 20220219 |
| Status | active |
| Date | 2022-02-19T01:06:51-05:00 |
| Name | RivaroxabanForVTEProphylaxis |
| Title | Rivaroxaban for VTE Prophylaxis |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for medications of rivaroxaban indicated for venous thromboembolism (VTE) prophylaxis and treatment.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for oral forms of rivaroxaban.),(Exclusion Criteria: No exclusions.) |
FHIR